AgaMatrix Company
AgaMatrix develops and manufactures a line of diabetes products designed to improve the quality of diabetes care. The company’s products feature WaveSense, a new technology that personalizes each test to provide world class accuracy. It detects and corrects for many errors caused by differences in blood samples and environmental conditions. Zero-Click™, the WaveSense diabetes data management system, was designed to simplify data download. WaveSense and Zero-Click consist of six FDA-cleared products and are protected by a suite of more than 160 patents worldwide.
Industry:
P4 Medicine
Headquarters:
Salem, New Hampshire, United States
Zip:
101-250
Founded Date:
2001-01-01
Employees Number:
101-250
Acquisitions Number:
7
Investors Number:
152200000
Total Funding:
$10M to $50M
Estimated Revenue:
$10M to $50M
Last Funding Date:
Debt Financing
Last Funding Type:
info@agamatrix.com
Register and Claim Ownership